Drugs / Novomix
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | NovoMix | — | 2000-08-01 | europa.eu ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02987751 Comparator | Dec 2016 → Sep 2018 | type 2 diabetes mellitus | India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Novomix | “Novomix” NCT02987751 ↗ |
| Modality | Protein / enzyme biologic | “Premixed analogue insulin (70/30)” NCT02987751 ↗ |